stars 1 stars 2 stars 3

Galenica is one of the largest Greek pharmaceutical companies which promotes research and serves health with consistency and scientific responsibility, by developing high-quality and innovative pharmaceutical products. Founded in 1974 by the pharmacists Denis Varelas and Basile Tamvacas, it became very soon one of the most dynamic companies in the sector with impressive rates of growth and development. It is the first Greek company that focused on the acquisition of know how and marketing of ethical products, through the cooperation with well established foreign research based pharmaceutical companies. It is also focused on the development of its own proprietary original pharmaceutical products, which are already exported successfully in Balkan countries. Since the last years, the company invests on the field of biotechnology, realizing the important role that this science plays in the discovery of new methods, both for the treatment and the prevention of diseases. One of the key factors of the company’s success is its people that nowadays amount up to 300 headcounts

View Top Employees from GALENICA S.A.

GALENICA S.A. Questions

The GALENICA S.A. annual revenue was $37 million in 2024.

Nicholas Varelas is the CEO of GALENICA S.A..

112 people are employed at GALENICA S.A..

The NAICS codes for GALENICA S.A. are [541, 5417, 541713, 54171, 54].

The SIC codes for GALENICA S.A. are [87, 873].

How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
talentculture2022
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users